Vaxcell-Bio Therapeutics Inc. (323990)
Market Open
10 Aug, 06:30
KRX SM KRX SM Primary ₩
4,435. 00
+265
+6.3549%
₩
241.01B Market Cap
- P/E Ratio
- Div Yield
128,353 Volume
- Eps
₩ 4,170
Previous Close Want to track 323990 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vaxcell-Bio Therapeutics Inc. (323990) Statistics
Valuation metrics
Market Cap 241.01B
Enterprise value 88.05B
Trailing P/E (ttm) -6.57
Forward P/E -
PEG ratio 0.23
Price/Sales (ttm) 14.06
Price/Book (mrq) 1.69
Enterprise Value/Revenue 12.81
Enterprise Value/EBITDA -10.68
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 94.72K
Average volume (90 days) 168.69K
Price summary
52-Week low 3,350
52-Week high 11,520
Beta -
50-Day moving average 4,215.71
200-Day moving average 6,840.74
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 10 Nov 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.14%
Operating margin -2.32%
Operational effectiveness
Return on assets -0.23%
Return on equity -0.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 296.56
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -634.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 847.51
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 6.15%
Book value per share (mrq) 2,469.27
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
